Cytokine PharmaSciences Completes Phase II Study of Controlled Release Misoprostol Vaginal Insert (MVI)
6/15/2010 10:10:22 AM
More...
|
Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
11/30/2009 9:20:34 AM
More...
|
Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
7/20/2009 9:00:19 AM
More...
|
Cytokine PharmaSciences Presents Non-Clinical Data From Its Smooth Muscle Contractility Program at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition
5/7/2009 11:02:37 AM
More...
|
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
2/25/2008 8:50:15 AM
More...
|
Cytokine PharmaSciences Announces Oral Efficacy of Anti-Cytokine Semapimod
10/29/2007 7:59:01 AM
More...
|
Cytokine PharmaSciences Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
8/2/2007 12:04:41 PM
More...
|
Cytokine PharmaSciences Issued Patent for MIF Gene Polymorphism Diagnostics
5/3/2007 11:08:54 AM
More...
|
Presidio Pharmaceuticals Licenses Nuclear Exclusion Compounds From Cytokine PharmaSciences
1/9/2007 12:13:15 PM
More...
|
Beijing Med-Pharm Corp. (BJGP.PK) And Cytokine PharmaSciences Reach Agreement On Development And Commercialization Of Second-Generation Obstetrics Product In China
11/29/2006 12:08:48 PM
More...
|
|